| 000 | 01130 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513160553.0 | ||
| 264 | 0 | _c19990121 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/s0960-894x(98)00609-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDubowchik, G M | |
| 245 | 0 | 0 |
_aCathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cDec 1998 |
||
| 300 |
_a3341-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 |
_aDipeptides _xchemical synthesis |
| 650 | 0 | 4 |
_aDoxorubicin _xchemical synthesis |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aProdrugs _xchemical synthesis |
| 700 | 1 | _aFirestone, R A | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 8 _gno. 23 _gp. 3341-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(98)00609-x _zAvailable from publisher's website |
| 999 |
_c9836148 _d9836148 |
||